This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
1 Smart Insulin Pen Cap System Shows Sustained Glycemic Improvement Over 12 Months | ADA 2025 / Orawan - stock.adobe.com The system, called the Bigfoot Unity Diabetes Management System, integrates with the FreeStyle Libre 2 sensor and supports commonly used insulin pens to simplify diabetes care. at baseline to 8.0±1.2%
Pharmacists can also provide diabetes management as an embedded member of clinic or hospital locations. July 15, 2025. Accessed July 21, 2025. Accessed July 21, 2025. The FDA approved insulin aspart-xjhz (Kirsty) 100 units/mL as the first and only interchangeable biosimilar to insulin aspart (NovoLog). News release.
Recent Videos Related Content Q&A: How Advancements in GLP-1s, CGM Impact Insulin Management Brian Nowosielski ; Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES July 15th 2025 Article Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses how diabetes advancements like GLP-1s and CGM have impacted the management of insulin.
A collaborative and patient-centered approach is crucial in improving polypharmacy outcomes, according to a study published in Intelligent Hospital. Intelligent Hospital. Published online June 29, 2025:100006. Accessed July 18, 2025. The dangers of polypharmacy and the case for deprescribing in older adults.
Most of the students observed burnout among community chain pharmacists (90%), then community independent (69%), and hospital and health system (65%). April 24, 2025:100049. June 16, 2025. Accessed July 9, 2025. Accessed July 9, 2025. Etter N, Gerhards K. University of Wisconsin School of Pharmacy.
Recent Videos Related Content Q&A: Pharmacists Play Essential Role in Insulin Therapy Success Killian Meara ; Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM July 15th 2025 Article Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, discusses how pharmacists can help patients manage insulin.
The Evolving Landscape of Insulin Delivery in Diabetes Management Brian Nowosielski ; Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES July 17th 2025 Podcast Amid increased advancements in diabetes management, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed how these developments are currently impacting the delivery of insulin.
READ MORE: Insulin Advancements Led to Safer Surgeries, Shorter Hospital Stays Drug Topics : How has the administration of insulin management been impacted by medical advancements in things like CGM and GLP-1 medications? Diana Isaacs: It's really interesting. Subscribe Now!
Additional advantages include fewer emergency visits, hospitalizations, medication adherence, and associated cost savings. The study also sought to determine the rate of achieving goal A1c, mean A1c reduction, and rate of hospitalization and emergency department visits. 2025 May 6:102413. million people, or 11.6% References 1.
In a session at the Pharmacy Quality Alliance Annual Meeting 2025, presenters stated that approximately 68% of patients have at least 1 unmet SDOH. The Mount Sinai Hospital. June 18, 2025. Accessed June 18, 2025. Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025. May 15, 2025.
In a review earlier in 2025, it was estimated that adolescent obesity affects 21% of patients aged 12 to 18 years. January 30, 2025. Accessed July 21, 2025. GLP-1 Use Increased Significantly Among Pediatric Patients With T2D in Past 5 Years | ADA 2025. June 25, 2025. Accessed July 21, 2025. Drug Topics.
2 Pharmacists can play a large role in the management of IBD, especially because medication nonadherence is common, leading to increased flares, hospitalizations, and complications. June 4, 2025. Accessed June 6, 2025. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Accessed June 6, 2025. Mayo Clinic.
In response to this, the Leeds Teaching Hospitals NHS Trust (LTHT) pharmacy team has recently launched its ‘Digital Induction’ document. This Charter was launched in February 2025, based on common sense and feedback from a digital wellbeing survey which was run prior to its launch.
As lawmakers in Lansing debate health care legislation, new evidence reveals a staggering—and deeply troubling—reality: big, tax-exempt hospitals in the state are marking up the price of prescription medicines by nearly $10 billion a year.
Mickey Mouse wishes he had the profit margins of some hospitals. The tax-exempt, religious system, which runs 53 hospitals across nine states, generated a 17% operating margin and 23% net margin, inclusive of investments, in the first three months of 2025.
Qualified Health and Collate , two early stage generative AI startups, targeting hospitals and pharma respectively, each announced $30 million in funding.
Sustainability has become central to the mission of hospital pharmacists, who are uniquely positioned to minimise waste, reduce healthcares environmental footprint and enhance patient outcomes. As climate concerns intensify, hospital pharmacists increasingly recognise the significant impact of their decisions on both patients and the planet.
That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025. Editor's Footnote In May 2025, Secretary Robert F. Updated June 27, 2025.
Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program.
As an overall patient safety and medicines quality measure, hospital pharmacists in Belgium have mitigated critical risks in the supply chain for chimeric antigen receptor (CAR) T-cell therapies. This delegation of tasks effectively sidelines the hospital pharmacist from the CAR T treatment pathway. 2025 Mar 6:ejhpharm-2024-004454.
But in 2025, RPM patient consent compliance is more than a billing formality; it is a legal, regulatory, and ethical imperative. To ethically deploy RPM in 2025: Providers must clearly explain how data flows across the care team Patients should know what third parties (e.g., April 15, 2025. Accessed June 26, 2025].
The Royal Pharmaceutical Society is calling on the Government to commit to upgrading digital systems in hospital pharmacy as the chancellor Rachel Reeves announces her much-anticipated spending review. The NHS will receive a £29bn real terms funding boost over the next three years, Ms Reeves said.
Furthermore, an investigation conducted by Norwalk et al found significant differences between Black and non-Black populations in pneumococcal mortality and length of hospital stay. Racial disparities in adult pneumococcal vaccination indications and pneumococcal hospitalizations in the US. J Natl Med Assoc. 2019;111(5):540-545.
However, in many clinical settings, including hospital wards, a prescribed tablet strength may not be available, or a patient might have difficulty swallowing solid oral dosage forms. In 2017, it set an ambitious goal to reduce severe, avoidable medication errors by 50% within five years.
PQA will welcome Melody Evans and Lauren Moy in June for the 2025-26 year. As the 2024-2025 Student National Pharmaceutical Association (SNPhA) Region III Facilitator, she oversaw 25 pharmacy school chapters, launching initiatives to promote collaboration and professional development. Learn more about her in this Q&A.
Introduction: In 2025, programmatic advertising will continue to redefine how pharmaceutical brands reach healthcare providers (HCPs) and patients. In this article, well explore key programmatic trends for 2025 and how they can help your campaigns become more targeted, efficient, and compliant.
Medicares increasing focus on quality metrics in 2025 presents critical challenges for healthcare providers. Critical Timelines: Performance Year 2024: Providers must track and manage quality metrics from January 1 to December 31, 2024, focusing on key areas such as medication adherence and hospital readmission rates.
Accessed July 23, 2025. Accessed July 23, 2025. Pneumococcal disease—pneumococcal vaccine recommendations. Last Updated October 26, 2024. CDC—AdultVaxView. Vaccination coverage among adults in the United States, National Health Interview Survey, 2022. Last Updated October 4, 2024. Hong K, Zhou F, Tsai Y, et al.
May 24, 2025. As immune evasion remains a major barrier in CLL treatment, this dual-action approach may provide a powerful, novel approach to improve patient outcomes. REFERENCES 1. Drengler EM, Smith AL, Skupa SA, et al. BET Protein Inhibition Relieves MDSC-Mediated Immune Suppression in Chronic Lymphocytic Leukemia.
Here, speaking to Gerry Hughes, she shares her insights on current clinical pharmacy challenges around expansion and integration of hospital pharmacists, and the exciting trajectory this branch of pharmacy is set to undertake in the years ahead. Over previous decades, there have been several inflection points in its progress.
King Faisal Specialist Hospital & Research Centre (KFSHRC) has announced a landmark partnership with Germfree Laboratories to develop Saudi Arabia’s first fully integrated modular advanced therapy medicinal product (ATMP) manufacturing campus.
The final results from the trial are expected in the second half of 2025. Conducted at the centre for vaccinology (CEVAC), Ghent University Hospital, Belgium, the trial investigated the safety […] The post Osivax reaches key milestone in phase 2a trial for broad-spectrum flu vaccine appeared first on Pharmafile.
Experts Debate Diabetes Care in Community Pharmacy vs Health Systems Despite evidence of improved diabetes outcomes, all pharmacy settings are capable of having a significant impact on diabetes care, according to a presentation at the American Pharmacists Association (APhA) 2025 Annual Meeting and Exposition.
The triple combination medicine vanzacaftor/tezacaftor/deutivacaftor (brand name Alyftrek), which is manufactured by Vertex Pharmaceuticals, was licensed for use in the UK in March 2025 and will now become available immediately through the NHS in England.
The changes, developed following consultation with pharmacy professionals and stakeholders in 2023, are expected to come into effect by the end of 2025, with a one-year transition period for the bulk of the measures to allow for the development of professional standards and guidance.
And more specifically for pharmacists working in hospitals, there is also the potential for AI to be used to clinically verify or screen prescriptions and highlight those that need more input from an experienced oncology pharmacist due to specific parameters not being met.’
It involved pharmacist, hospital doctor and GP training on delivering structured medicine reviews and managing inappropriate polypharmacy. iMPROVE Launched on 1 March 2025, MOICs latest project is Innovation in person-centred Medication Prescribing and Review for Optimal Value and Efficacy (iMPROVE). June 2023 [Accessed April 2025].
Abigail Beaney July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The new legislation will reduce the time it takes for patients to receive these therapies from months to days. Go deeper with GlobalData Reports China Contract Manufacturing Market Outlook - Trends, Ambitions, Ke.
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, showcased significant advances across a range of malignancies, with novel agents, biomarker-driven strategies, and long-term outcomes data offering new insights into cancer treatment with implications for pharmacy practice. June 5, 2025.
Hospitalization occurs in 1% to 4% of cases, mostly involving immunocompromised individuals. July 17, 2025. Accessed July 18, 2025. Accessed July 18, 2025. Accessed July 18, 2025. Accessed July 18, 2025. While most experience shingles only once, recurrence is possible. News Release. October 23, 2017.
Noting a concerning vacancy rate, the pharmacy department at East Kent Hospitals University NHS Foundation Trust set about determining the reasons for this and identifying solutions. The recruitment and retention of clinical and non-clinical staff is a persistent challenge across secondary care services.
A tool to streamline hospital outpatient clinics for geriatric oncology patients has been developed by a clinical pharmacist and clinical nurse specialist at the Royal Marsden NHS Foundation Trust. Int J Clin Pharm (2025).
Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting.
Importantly, Novavax received FDA approval in May 2025 with restrictions: It is approved for individuals 65 years and older and patients aged 12 to 64 years with at least 1 health condition that puts them at risk for severe COVID-19. 5 This option should be available for patients for the 2025-2026 flu season.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content